ReviewPharmaceutical medicine2022
Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond.
Review in Pharmaceutical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.
- Smartphone-Based Digital Health Interventions: A Comprehensive Systematic Review of Efficacy for Cardiovascular and Cerebrovascular Outcomes.Journal of medical systems · 2025Pooled it
- Embracing Digital as a Paradigm Shift in Medical Affairs.Pharmaceutical medicine · 2026Review
- Transformation of a Medical Information Department to Meet the New Healthcare Realities of the Post-Pandemic Era.Pharmaceutical medicine · 2026Article
- Strengthening clinical research and practice in China's healthcare system: a decade of action via the NEJM pilot initiative.Medical review (2021) · 2026Article
- Telemedicine utilization and digital inclusion among people with disabilities in Saudi Arabia: post-pandemic associated factors and policy implications.Frontiers in public health · 2026Article
- Pioneering the Future of Medical Affairs: A Strategic Transformation to Meet the Spanish Healthcare Ecosystem's Evolving Trends.Pharmaceutical medicine · 2025Article
- Use and Acceptance of Innovative Digital Health Solutions Among Patients and Professionals: Survey Study.JMIR human factors · 2025Article
- Understanding the National Healthcare Ecosystem to Position Medical Affairs as a Strategic Element: Lessons Learned from AstraZeneca Spain.Pharmaceutical medicine · 2025Article
- Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities.Pharmaceutical medicine · 2024Review
- Cultivating Excellence: Future-Proofing Medical Affairs with Tailored Talent Programs.Pharmaceutical medicine · 2024Article
- How Can General Managers Best Leverage Medical Affairs Now and in the Future?Pharmaceutical medicine · 2024Article
- Health Care Workers' Motivations for Enrolling in Massive Open Online Courses During a Public Health Emergency: Descriptive Analysis.JMIR medical education · 2024Article
- Journey from an Enabler to a Strategic Leader: Integration of the Medical Affairs Function in ESG Initiatives and Values.Pharmaceutical medicine · 2023Article
- The Medical Science Liaison Role in Spain: Opinion of the Commercial Department Personnel.Therapeutic innovation & regulatory science · 2023Article
- Considerations for Effective Communication of Medical Information.Pharmaceutical medicine · 2023Article
- Enabling Virtual Learning for Biomechanics of Tooth Movement: A Modified Nominal Group Technique.Dentistry journal · 2023Article
- Pathways, technology and the patient-connected health through the lifecycle.Frontiers in digital health · 2023Review
- Leveraging Digital Health to Improve the Cardiovascular Health of Women.Current cardiovascular risk reports · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A number of developments, including increasing regulatory and compliance scrutiny, increased transparency expectations, an increasingly vocal patient, patient centricity and greater requirements for real-world evidence, have driven the growth and importance of medical affairs as a trusted, science-driven partner over the past decade. The healthcare environment is shifting towards a digital, data-driven and payor-focused model. Likewise, medical affairs as a function within the pharmaceutical industry has become more "patient-centric" with strategic engagements embracing payers and patients apart from clinicians. The pandemic has impacted the healthcare industry as well as the function of medical affairs in numerous ways and has brought new challenges and demands to tackle. There is indeed a silver lining due to intense digital transformation within this crisis. The emerging digital innovation and new technologies in healthcare, medical education and virtual communications are likely to stay and advance further. In this review, we discuss how the digital transformation sparked by the pandemic has impacted the medical affairs function in pharmaceuticals and provide further insights and learnings from the COVID-19 era and beyond. Based on the learning and insights, digital innovation in three key strategic imperatives of medical affairs-HCP engagement, external partnerships and data generation will enable medical affairs to become future-fit as a strategic leadership function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.